Rheumatologic manifestations of HIV/AIDS
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 5
Abstract
There has been a decline in the prevalence of HIV/AIDS and a decline in AIDS-associated deaths. However, the World Health Organization estimates that roughly 35 million people are living with HIV. Globally, there are still approximately 2 million new infections per year. Immunosenescence with the development of serological abnormalities is “an unknown quantity” in terms of Rheumatology manifestations and shall be a key to future diagnoses, investigations and treatments.
Authors and Affiliations
Michael G Blackmore
Treatment of early rheumatoid arthritis with certolizumab pegol after failure of diseasemodifying antirheumatic drugs: a report of two cases
Rheumatoid arthritis is a severe systemic inflammatory disease, characterized by polyarticular synovitis and subsequent structural changes to the cartilage. Diagnosis and treatment in the early disease stages are extreme...
Heart failure with preserved ejection fraction in rheumatoid arthritis and the role of interleukin-6 blockade
There is growing evidence on the potential benefits of tocilizumab on the cardiovascular system in Rheumatoid Arthritis (RA) patients. We discuss a case of active RA and refractory Heart Failure with Preserved Ejection F...
A case series of malignancies: mimics of Rheumatological disorders
Background: Malignancy and Autoimmunity interplay is full of complexities. We here, describe few cases of malignancies presented as mimics of autoimmune disorders. A case of acute myeloid leukaemia had leukocytoclastic v...
Characteristics of fibromyalgia patients prescribed opioid medications: data from the Cleveland Clinic Fibromyalgia Registry
Objective: Determine the prevalence, socioeconomic, clinical characteristics of fibromyalgia (FM) patients and the factors associated with narcotic drug prescription. Methods: New patients with FM referred for rheumatol...
Haemophagosytic limphohistiosytosis (HLH) in adults - clinical features, triggering diseases, prognostic factors and outcomes: Report of thirty-three cases
Objective: To analyse clinical features, triggering diseases, treatment strategies and prognostic factors in patients with secondary haemophagosytic limphohistosytosis (SHLH). Methods: We retrospectively analysed thirty...